Skip to main content

Closed

INKT: MiNK Therapeutics, Inc. Financial Statements & Revenue | finqOS

Healthcare · Biotechnology

52W Range

21thpctl

Volume

0.12×avg

Market Cap

52.31MUSD

P/E Ratio

-3.7TTM

Div Yield

-ann

MiNK Therapeutics, Inc.

INKTNASDAQ Capital Market·USD·Closed

MiNK Therapeutics, Inc.

INKTNASDAQ·USD·Closed

$10.50

−0.85%

$10.50

−$0.09 (0.85%)

52W Range

21thpctl

Volume

0.12×avg

Mkt Cap

52.31MUSD

P/E

-3.7TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings